west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "配伍禁忌" 8 results
  • Analysis of Clinical Unreasonable Use of Drug

    为了促进药物的合理应用,本文从药物相互作用、配伍禁忌、药物选用、用法用量等方面对临床常见的不合理用药医嘱进行了探讨,指出用药不当的原因和可能的后果,帮助临床有效地防范不合理用药的发生,有利于针对性地提高临床合理用药水平。

    Release date:2016-09-08 10:14 Export PDF Favorites Scan
  • Systematic Review on the Compatibility of Shuanghuanglian Injection Combined with Western Medical Injections△

    Objective Shuanghuanglian injection (SHLI) is a typical Chinese medicine injection which has been used for more than 20 years. This study aims to investigate the compatibility of SHLI with western intravenous agents. Methods An extensive literature search was executed to identify all experimental tests and clinical reports on the topics. Data on the types of infusion solutions and western medical injections, usage and dosage, outcome measures for physical and chemical properties, and changes of drug effect were searched for. The included data was analyzed and described by the category of included western drugs. Compatibility was tested through integrating the evaluations of physical properties, chemical composition, drug metabolism, and safety. Results Sixty articles (38 experimental tests and 22 clinical reports) were included after screening. Fifty–three western medical injections were identified from all the included articles. Most of the research was about the compatibility of SHLI with different types of antibiotics, including β-lactam, aminoglycoside, and quinolone etc. Thirty-one western medical injections were not recommended to be combined with SHLI. The quality of the experimental test design was low because of unbalanced evaluation indicators: more attention to physical changes than drug metabolism, effect, and safety. Conclusions A broad incompatibility exists in the combination of SHLI with western medical injections. Some results are still uncertain, but the combinations should still be avoided until researched clearly. The compatibility and interaction of Chinese herbal injections and western medicines is still a weak area. The pharmaceutical sector should strengthen post-market research to update evidence and improve its distribution.

    Release date:2016-09-07 11:13 Export PDF Favorites Scan
  • 多烯磷脂酰胆碱与奥硝唑注射液使用存在配伍禁忌

    Release date:2016-09-08 09:18 Export PDF Favorites Scan
  • Tabu in Chinese and Western Medicine Compatibility

    随着世界现代医药学和我国传统医药学的深入发展,中药和西药的在临床上的联合应用非常普遍。而目前在临床中西药合用过程中往往只注重中西药合用的有效性,却忽视了因配伍禁忌而可能出现疗效降低、产生或增加毒副作用的不合理用药。这不仅造成资源的浪费,同时也增加药源性疾病的发生。这应引起广大医药工作者及患者的高度重视。笔者参考近年来有关文献资料,就临床中西药合用的配伍禁忌问题进行归纳论述。

    Release date:2016-09-08 09:56 Export PDF Favorites Scan
  • 盐酸万古霉素与头孢哌酮钠舒巴坦钠使用存在配伍禁忌

    目的探讨在临床输液过程中,盐酸万古霉素与头孢哌酮钠舒巴坦钠使用存在配伍禁忌。 方法将头孢哌酮钠舒巴坦钠3 g加入生理盐水50 mL内,将盐酸万古霉素100万U加入生理盐水100 mL内,各抽取2 mL混匀,观察两组药物之间的反应。 结果将混合的液体在常温下放置10 min、1 h、2 h,观察混合液是否变澄清,但发现液体仍为浑浊液体。 结论盐酸万古霉素与头孢哌酮纳舒巴坦纳使用存在配伍禁忌。

    Release date: Export PDF Favorites Scan
  • 品管圈活动在防止静脉输液过程中发生配伍禁忌的应用

    目的探讨品管圈(QCC)活动对防范静脉输液过程中药物配伍禁忌发生的作用与效果。 方法于2012年10月创建QCC活动小组,针对药物配伍中发生的问题,通过加强护士培训,严格执行相关制度,强化管理督导等方法,防止药物配伍禁忌的发生。 结果实施QCC活动前药物配伍禁忌发生率为0.5%,实施QCC活动后无药物配伍禁忌事件发生。 结论QCC活动不仅提高了护士对药物配伍禁忌相关知识的知晓率、对制度的执行率,也提高了护士的责任心,为患者提供了更安全、高效的静脉输液护理服务,保证了患者住院期间的安全。

    Release date: Export PDF Favorites Scan
  • 钠钾镁钙葡葡糖注射液与埃索美拉唑钠存在配伍禁忌

    Release date: Export PDF Favorites Scan
  • 钠钾镁钙葡萄糖注射液与注射用奥美拉唑钠存在配伍禁忌一例

    Release date:2017-02-22 03:47 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content